Similar Items: Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
- Herpes Zoster Risk in Rheumatoid Arthritis Patients on Janus Kinase Inhibitors: A 17-Year Experience from Rheumatoid Arthritis Saudi Database (RASD)
- Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort
- Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting
- The association between bariatric surgery and incident rheumatoid arthritis
- The prevalence of interstitial lung disease in rheumatoid arthritis: a systematic review
- Correction to “Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders”